David L. Shriner
About
In The Last Decade
David L. Shriner
10 papers receiving 484 citations
Peers
Comparison fields: 5 of 76
- Dermatology 258
- Epidemiology 254
- Oncology 164
- Surgery 89
- Pharmaceutical Science 85
Countries citing papers authored by David L. Shriner
This map shows the geographic impact of David L. Shriner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Shriner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Shriner more than expected).
Fields of papers citing papers by David L. Shriner
This network shows the impact of papers produced by David L. Shriner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Shriner. The network helps show where David L. Shriner may publish in the future.
Co-authorship network of co-authors of David L. Shriner
This figure shows the co-authorship network connecting the top 25 collaborators of David L. Shriner. A scholar is included among the top collaborators of David L. Shriner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Shriner. David L. Shriner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 35 | |
| 2 | 295 | |
| 3 | 23 | |
| 4 | 6 | |
| 5 | 91 | |
| 6 | Informed consent and risk management in dermatology: to what extent do dermatologists disclose alternate diagnostic and treatment options to their patients? | 2 |
| 7 | 19 | |
| 8 | Photography for the early diagnosis of malignant melanoma in patients with atypical moles. | 25 |
| 9 | 3 | |
| 10 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.